1; Bywaters, J L, and Knox, E G, Lancet, 1976 , 1, 849. (Accepted 17 May 1978 Bone scanning in breast cancer Preliminary statement by British Breast Group on Bone Scanning* British Medical Journal, 1978, 2, 180-181 Bone scans are being used increasingly for detecting skeletal metastases that are not radiologically demonstrable in women with primary breast cancer. Some surgeons are acting on the results of these scans to determine the best form of primary treatment. Information from other centres has confirmed the finding of Galaskol that a positive bone scan-that is, a focal area of increased uptake which is asymmetrical and not associated with pre-existing skeletal disease-indicates a metastatic deposit and a bad prognosis. The reported incidence of positive scans varies, however, and in no series approaches the true prevalence of skeletal metastases.
We therefore thought it worth while to survey the results of bone scans in women with primary disease in eight centres in Britain (see table) , all experienced in the management of breast cancer. We held a meeting for this purpose in Manchester in October 1976, to which colleagues from departments of radiology and nuclear medicine were invited. Recent interest in the 
Methods
Although some of the centres surveyed had previously used 18F and 87mSr as radioisotopes for skeletal scintiscanning, all used one of the 99mTc-labelled phosphate derivatives, the diphosphonate compound being the most popular, at the time of the study. These agents yield a low radiation dose, which allows short imaging times from relatively large doses of the radiopharmaceutical; have a high target to background ratio; and are readily available and cheap. The scanning equipment varied from centre to centre, but gamma cameras were most commonly used (see table) . In some centres rectilinear scanners were preferred but only one centre used a multicolour device for printout. There is increasing interest in computer-linked equipment but none of the centres included was using it routinely. Future developments may be expected to increase the quality of the pictures and the precision of analysis.
Results
The results in 994 patients were available for analysis. All had operable breast cancer. The clinical classification of their disease (TNM) and the number of positive bone scans is shown in the table for each centre. The variation ranged from 1 9 to 2022%, with an average of 101%. 
Discussion
The average rate of positive bone scans in this survey did not reach that reported by Galaskol in patients with primary breast cancer. He studied 50 patients with TI, 2, 3, NO, 1 tumours (two were T3 on size alone) who had no clinical evidence of metastatic disease; all underwent scintiscanning with 18F and a gamma camera, and 12 had positive scans. All of these 12 patients developed disseminated disease within five years.3 Even higher frequencies of positive scans in stage I and II disease have been reported but these are as yet unconfirmed.
The variation that we found among centres using technetium phosphate compounds is unlikely to be explained on the basis of different staging of the disease. All centres are experienced in the clinical staging of patients with breast cancer and the cases included in the survey were generally similar. Technical variations may have accounted for some of the differences; indeed, in one patient with a negative scan in one centre a repeat scan in another centre within a week was positive. Nevertheless, there were no apparent major differences in techniques among centres that might have accounted for such wide variations. The reasons may become clear on further follow-up of the patients once the positive conversion rates on repeat scans are known. 4 As the progress of all 994 patients will be reviewed, we will be able to assess the accuracy of these techniques in defining occult metastatic disease in bone.
We report these results to draw attention to unexplained variations and to emphasise the need for stringent control of the quality of scans and more information about their interpretation before they can be used to determine the management of patients with early breast cancer.
Today's Treatment
Use of antibiotics Septicaemia A M GEDDES British Medical3Journal, 1978, 2, 181-184 Septicaemia is life-threatening. Its diagnosis should, if possible, be made clinically as any delay in starting treatment may result in the death of the patient. Bacteriological confirmation of the diagnosis may take up to 48 hours, and even then the results of blood cultures may be negative as a result of prior administrations of antibiotics or because the infecting organism is sequestrated in an abscess but releasing toxin into the blood stream. Whereas the term "bacteraemia" merely refers to the presence of bacteria in the blood, "septicaemia" denotes the clinical syndrome caused by these organisms. Bacterial toxins, especially those produced by Gram-negative bacilli, can damage vital organs such as the kidney, heart, brain, and liver and can also produce shock. Organ failure may result, and this may alter the metabolism and excretion of certain antibiotics with resultant toxicity in some instances.
Diseases associated with septicaemia and the micro-organisms commonly causing septicaemia are listed in sources of septicaemia are the microbiologically "dirty" areas of the body-namely, the oronasopharynx, colon, genital tract, and skin. The very young and the elderly are particularly susceptible to septicaemia, which is also common in patients whose defence mechanisms are compromised by diseases such as malignancy or immune deficiency or by mechanical factors, such as intravenous cannulae or bladder catheters. Immunosuppressive or corticosteroid drugs also predispose to septicaemia. Septicaemia is a not uncommon cause of death after organ transplantation and other major surgical operations. It may also complicate burns and renal dialysis.
Clinical features
The clinical features of septicaemia may be principally those of the associated disease-for example, meningitis or pyelonephritis. Septicaemia should be suspected, however, if a patient develops rigors or suddenly becomes seriously ill with fever. Occasionally, especially in the elderly or in the neonate, the patient may be afebrile. A fall in the blood pressure is common leading to decreased tissue perfusion causing cyanosis and sometimes renal failure. The spleen may be palpable, and the patient may develop a petechial or macular rash.
In the elderly patient septicaemia may present as a toxic psychosis with confusion, disorientation, and amnesia. A rapidly rising serum urea concentration suggests septicaemia, while the
